Study Finds Experimental Alzheimer’s Drug Slows Cognitive Decline
A large clinical trial of Eli Lilly’s experimental Alzheimer’s medication, donanemab found the drug slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third.
New Approach May Better Treat SLE
Findings in a recent study suggest that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus.
Blood-Based Biomarkers Can Detect Alzheimer’s 10 Years Before Disease Onset
A new study shows that a protein called glial fibrillary acidic protein is a possible biomarker for very early stages of Alzheimer’s.
Study Links Persistent Tumor Mutation with Therapeutic Response to Immunotherapy Schedule
Investigators have found that a subset of mutations within the overall tumor mutation burden are less likely to be edited out as cancer evolves.
CDC Adds COVID-19 Vaccine to Its Routine Immunization Schedule
The Centers for Disease Control and Prevention updated its schedule of recommended immunizations to include COVID-19 shots and boosters for children, adolescents and adults.
NIH Provides $5.3 Million Grant to Study Down Syndrome
The first clinical trial for Down syndrome regression disorder is being funded by a five-year $5.3 million grant.
HHS Issues Bulletin to Highlight Online Tracking Technology Obligations Under HIPAA Rules
The Office for Civil Rights issued a bulletin to highlight the obligations of the Health Insurance Portability and Accountability Act of 1996 on covered entities and business associates when using online tracking technologies.
$245 Million Awarded by HHS to Support Youth Mental Health
The U.S. Department of Health and Human Services has awarded nearly $245 million in Bipartisan Safer Communities Act funding to support the integration of mental health training into the training of primary care clinicians.
HHS Invests $13 Million to Grow and Strengthen the Nursing Workforce
The U.S. Department of Health and Human Services has awarded $13 million to bolster nursing education and training to grow the nursing workforce and improve access to nursing education.
Post-AMI Infusion of Human Apolipoprotein A-1 (CSL112) Strongly Boosts Impaired Cholesterol Efflux Capacity
Infusion of CSL112, an investigational human plasma-derived apolipoprotein A-1 formulated with phosphatidylcholine, rapidly and strongly elevates impaired cholesterol efflux capacity following acute myocardial infarction.
